Self-Assembling Peptide Hydrogels Kill MRSA and Other Drug-Resistant Bacteria While Being Safe for Wound Healing | Research

The takeaway

Two novel nucleopeptides that self-assemble into hydrogels showed potent activity against MRSA (MIC 15-17 μM) and other MDR clinical isolates while being highly biocompatible and compatible with wound healing.

MIC 15-17 μM vs MRSA with IC50 0.5-1.1 mM
The nucleopeptides kill MRSA at concentrations 30-70 times lower than what harms human cells — a wide safety window that's essential for topical wound care applications.

What the researchers found

Two thymine-conjugated nucleopeptides formed hydrogels in water at neutral pH via antiparallel β-sheet structures with π-π stacking and H-bonding. Antimicrobial activity against MDR clinical isolates: MRSA (MIC 15.92-16.86 μM), K. pneumoniae (MIC 8.8-50 μM), P. aeruginosa (active), plus standard B. subtilis and E. coli. Biocompatibility was excellent: IC50 values of 0.5-1.1 mM on HEK-293 cells (30-70× higher than MIC values). In vitro wound healing assays confirmed no disruption of cell or mitochondrial membranes. Nanostructural characterization showed nanofibrillar networks by TEM.

Why it matters

MRSA and other MDR pathogens cause life-threatening wound infections with limited treatment options. A self-assembling peptide hydrogel that kills superbugs on contact while being safe for human tissue could serve as an antimicrobial wound dressing — applied directly to infected wounds to kill bacteria and support healing simultaneously. The wide therapeutic window (30-70× between MIC and IC50) is particularly promising for clinical safety.

How the study worked

Two amphiphilic nucleopeptides were synthesized by conjugating thymine with peptide amphiphiles. Structural characterization used XRD, FETEM, and various analytical techniques. Self-assembly and hydrogel formation were assessed at neutral pH. Antimicrobial activity was tested against standard ATCC strains and MDR clinical isolates by MIC determination. Biocompatibility was evaluated by MTT assay on HEK-293 cells. Wound healing compatibility was assessed using an in vitro scratch assay with HeLa cells and fluorescence microscopy for membrane/mitochondrial integrity.

What this study cannot tell us

All experiments were in vitro — no animal wound infection models were used. The MIC values against P. aeruginosa were not specified in the abstract. Hydrogel stability, degradation rate, and sustained antimicrobial release were not characterized. The wound healing assay used HeLa cells (cervical cancer line) rather than primary skin cells or keratinocytes. Long-term biocompatibility and potential immune responses to the thymine-peptide conjugates were not assessed. Manufacturing scalability and cost were not discussed.

How to read the evidence

This is an in vitro materials science and antimicrobial study with thorough characterization of both structure and biological activity. The use of clinical MDR isolates (not just laboratory strains) strengthens the antimicrobial relevance. However, no in vivo data exists.

When this study was published

Published in 2025, this study represents a current approach to the antibiotic resistance crisis — combining peptide self-assembly technology with antimicrobial function for wound care applications.

The bigger picture

Nucleopeptides — hybrid molecules combining nucleic acid bases with peptides — represent a newer approach in antimicrobial design. The self-assembling hydrogel property is particularly valuable because it enables the peptides to be applied as a gel to wound surfaces, where they can maintain high local antimicrobial concentrations while providing a moist wound healing environment. This combines two clinical needs (antimicrobial + wound care) in a single material.

Questions still open

Do these nucleopeptide hydrogels maintain antimicrobial activity and promote wound healing in animal infection models?
How long does the hydrogel maintain antimicrobial concentrations at the wound site before degrading?
Could the nucleobase component (thymine) be varied to optimize antimicrobial potency or add additional functions like nucleic acid binding?

Common questions

What are nucleopeptides and how do they fight superbugs?

Nucleopeptides are hybrid molecules that combine a DNA building block (in this case thymine) with an antimicrobial peptide sequence. They spontaneously form gel-like nanofiber structures in water that can kill drug-resistant bacteria like MRSA on contact. The gel format makes them ideal for application to infected wounds, where they can maintain high antimicrobial concentrations right where they're needed.

Are these peptide gels safe to put on wounds?

The lab tests are very encouraging. The peptides kill bacteria at concentrations 30-70 times lower than what's harmful to human cells, giving a wide safety margin. Wound healing tests showed no damage to cell membranes or mitochondria. While animal studies and human testing are still needed, the in vitro safety profile is better than many antimicrobial peptides.

Read the original research

Self-Assembling Nucleopeptides Exhibiting Strong Antimicrobial Activity against Multidrug-Resistant Clinically Isolated Strains and In Vitro Wound Healing Compatibility.

ACS applied bio materials, 8(4), 3061-3075

View on PubMed ↗Publisher’s paper ↗

Citation

Deb, Swapnendu; Gupta, Shalini; Bose, Supratim; Mondal, Tanushree; Mondal, Biplab; Banerjee, Arindam. (2025). Self-Assembling Nucleopeptides Exhibiting Strong Antimicrobial Activity against Multidrug-Resistant Clinically Isolated Strains and In Vitro Wound Healing Compatibility.. ACS applied bio materials, 8(4), 3061-3075. https://doi.org/10.1021/acsabm.4c01891